Monday, Dec 4, 2023 | 12:00 AM ET

S4 E11: Striking the Right Balance: Regulating AI in Healthcare

Balancing regulation with innovation is crucial when it comes to AI and healthcare.

In this episode, Shannon Klinger, the Chief Legal Officer and Corporate Secretary at Moderna, shares her inspiring journey, emphasizing the pivotal role of AI in Moderna's research and development. She highlights how AI and digital technology are at the core of Moderna's strategy, significantly increasing mRNA production for clinical trials, including during the COVID-19 pandemic. Shannon stresses that each day can impact and save patients' lives, and she advocates for the harmony between speed and innovation. Finally, she explores the healthcare sector's need to find a balance between regulating AI and fostering innovation.

Tune in to discover how Moderna leverages technology to democratize healthcare solutions, making a profound difference in people's lives.

About Shannon Klinger:

Shannon Thyme Klinger, the Chief Legal Officer and Corporate Secretary at Moderna is in charge of Moderna's legal and corporate compliance matters. Throughout her career, Shannon has been dedicated to improving long-term business performance, building trust with the public, ensuring access to medicine, and facilitating successful product launches. She is also a strong supporter of diversity, equity, and inclusion. Additionally, she served on the board of directors of the SIX Group in Switzerland from 2016 to 2020.

Shannon earned her Juris Doctorate with honors from the University of North Carolina at Chapel Hill and a bachelor's degree in psychology from the University of Notre Dame. She is a member of the State Bar of Georgia and the District of Columbia Bar.

Things You’ll Learn:

  • Many individuals choose healthcare as their career path due to their personal experiences.
  • Regarding AI and healthcare, balancing regulation and innovation is crucial.
  • Organizations should ethically use AI applications for the benefit of the public.
  • Excessive regulation can hinder the pace of innovation, potentially leading to fewer lives being protected.
  • Imagine the impossible and make it possible.
  • Moderna's goal is to ensure that people worldwide, regardless of their place of birth, have access to high-quality treatments.


  • Connect with and follow Shannon Klinger on LinkedIn.
  • Follow Moderna on LinkedIn.
  • Discover the Moderna Website.
  • Check out the mRNA Access Website.
  • Visit Moderna’s Charitable Foundation Website.
  • Listen to Shannon’s previous interview here.


Shannon Thyme KlingerChief Legal Officer, Moderna

You May Also Enjoy

January 3, 2023

S3 Ep1: Disrupting Episodic Care with Technology—f...

Jaime Murillo, MD, Senior Vice President, OptumLabs

January 31, 2024

S4 E34: Closing Gaps in Cancer Care

Harlan Levine, M.D., President, Health Innovation and Policy, City of Hope

April 11, 2023

S3 Ep 29: Actionable Insights to Change Healthcare...

Jean Drouin, Chief Executive Officer & Founder, Clarify Health

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved